PTEN: Difference between revisions
Ann Taylor (talk | contribs) No edit summary |
Nathan Line (talk | contribs) No edit summary |
||
Line 11: | Line 11: | ||
===MUTATIONS OF PTEN IN CANCER=== | ===MUTATIONS OF PTEN IN CANCER=== | ||
PTEN is | PTEN is a tumor suppressor protein that is mutated in several human cancers. These include glioblastomas, endometrial carcinomas, prostate carcinomas, and melanoma cases. PTEN has 403 amino acids which are separated into <scene name='Nathan_Line_sandbox/Structure/6'>two domains.</scene> The red section represents the C2 domain which allows the protein to intereact with the membrane. The phosphatase section (blue) interacts with the ligand and the phosphate head. These interactions are controled by two separate loops, the P-loop and the "TI" loop. | ||
<scene name='Nathan_Line_sandbox/Actice_site/1'>TextToBeDisplayed</scene> | <scene name='Nathan_Line_sandbox/Actice_site/1'>TextToBeDisplayed</scene> |
Revision as of 00:14, 6 October 2009
This is a placeholderThis is a placeholder
This is a placeholder text to help you get started in placing a Jmol applet on your page. At any time, click "Show Preview" at the bottom of this page to see how it goes.
Replace the PDB id (use lowercase!) after the STRUCTURE_ and after PDB= to load and display another structure.
MUTATIONS OF PTEN IN CANCERMUTATIONS OF PTEN IN CANCER
PTEN is a tumor suppressor protein that is mutated in several human cancers. These include glioblastomas, endometrial carcinomas, prostate carcinomas, and melanoma cases. PTEN has 403 amino acids which are separated into The red section represents the C2 domain which allows the protein to intereact with the membrane. The phosphatase section (blue) interacts with the ligand and the phosphate head. These interactions are controled by two separate loops, the P-loop and the "TI" loop.